Posted: July 30, 2007

The story of a nanotechnology start-up

(Nanowerk News) PharmaTelevision talks to Professor Tom Rademacher a professor at University College London (UCL)'s Immunology & Molecular Pathology Department, and President of Midatech, about the formation of the Midatech, Professor Rademacherís fifth start-up company. Midatech is focused on exploring the possibilities of nanotechnology, particularly for medical therapeutic and diagnostic applications.
Specifically, the company is a manufacturer of biocompatible nanoparticles called nanocells. They possess a number of unique properties that make them ideal for therapeutics, diagnostics and other enabling applications.
He also talks in depth about the science behind the company's nanoparticle technology, as well as its applications in therapeutics, diagnostics and surface coatings.
Source: UCL
Subscribe to a free copy of one of our daily
Nanowerk Newsletter Email Digests
with a compilation of all of the day's news.
These articles might interest you as well: